My Quote Request
No products added yet
6505-01-293-5580
20 Products
ZILACTIN GEL
TANNIC ACID GEL
NSN, MFG P/N
6505012935580
NSN
6505-01-293-5580
MFG
ZILA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V TANNIC ACID ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TANNIC ACID GEL 7% 0.25OZ TUBE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZILA PHARMACEUTICALS INC
PRIMARY CONTAINER CONTENT QUANTITY: 0.250 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: USE PREFERRED UPC: 3-50486-46802-4 IN ACCORDANCE WITH THE JDF
Related Searches:
NDC00065-0259-15
HYDROXYETHYLCELLULO
NSN, MFG P/N
6505012929823
NSN
6505-01-292-9823
MFG
ALCON LABORATORIES INC .
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: .5 PCT. W/V HYDROXYETHYLCELLULOSE EQUIVALENT; STERILE; BUFFERED; ISOTONIC; 15 ML BOTTLE WITH OPHTHALMIC TIP; SQUEEZE BOTTLE; PROVIDES A REFRACTIVE INDEX OF APPROXIMATELY 1.35; FOR BONDING GONIOSCOPIC PRISM TO THE EYE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYETHYLCELLULOSE OPHTHALMIC SOLUTION 0.5% 15ML BT
Related Searches:
ACCUTANE
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929831
NSN
6505-01-292-9831
MFG
ROCHE LABORATORIES INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.06 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 2.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.30 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOTRETINOIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOTRETINOIN CAPSULES 10MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
ACCUTANE CAPSULES
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929831
NSN
6505-01-292-9831
ACCUTANE CAPSULES
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929831
NSN
6505-01-292-9831
MFG
ROCHE LABORATORIES INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.06 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 2.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.30 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOTRETINOIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOTRETINOIN CAPSULES 10MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00004-0155-49
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929831
NSN
6505-01-292-9831
NDC00004-0155-49
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929831
NSN
6505-01-292-9831
MFG
ROCHE LABORATORIES INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.06 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 2.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.30 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS ISOTRETINOIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOTRETINOIN CAPSULES 10MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
ACCUTANE
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929832
NSN
6505-01-292-9832
MFG
ROCHE LABORATORIES INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.06 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 2.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.30 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOTRETINOIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOTRETINOIN CAPSULES 40MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
ACCUTANE CAPSULES
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929832
NSN
6505-01-292-9832
ACCUTANE CAPSULES
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929832
NSN
6505-01-292-9832
MFG
ROCHE LABORATORIES INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.06 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 2.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.30 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOTRETINOIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOTRETINOIN CAPSULES 40MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00004-0156-49
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929832
NSN
6505-01-292-9832
NDC00004-0156-49
ISOTRETINOIN CAPSULES,USP
NSN, MFG P/N
6505012929832
NSN
6505-01-292-9832
MFG
ROCHE LABORATORIES INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.06 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 2.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.30 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ISOTRETINOIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ISOTRETINOIN CAPSULES 40MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00264-1128-50
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012931338
NSN
6505-01-293-1338
NDC00264-1128-50
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012931338
NSN
6505-01-293-1338
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
S1285
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012931338
NSN
6505-01-293-1338
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
CREON
PANCRELIPASE CAPSULES,MODIFIED
NSN, MFG P/N
6505012931904
NSN
6505-01-293-1904
MFG
REID ROWELL
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 30,000 USP UNITS AMYLASE,8,000 USP UNITS LIPASE,AND 13,000 USP UNITS PROTEASE
Related Searches:
CREON CAPSULES
PANCRELIPASE CAPSULES,MODIFIED
NSN, MFG P/N
6505012931904
NSN
6505-01-293-1904
CREON CAPSULES
PANCRELIPASE CAPSULES,MODIFIED
NSN, MFG P/N
6505012931904
NSN
6505-01-293-1904
MFG
REID ROWELL
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 30,000 USP UNITS AMYLASE,8,000 USP UNITS LIPASE,AND 13,000 USP UNITS PROTEASE
Related Searches:
NDC00032-1200-07
PANCRELIPASE CAPSULES,MODIFIED
NSN, MFG P/N
6505012931904
NSN
6505-01-293-1904
NDC00032-1200-07
PANCRELIPASE CAPSULES,MODIFIED
NSN, MFG P/N
6505012931904
NSN
6505-01-293-1904
MFG
REID ROWELL
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 250.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 30,000 USP UNITS AMYLASE,8,000 USP UNITS LIPASE,AND 13,000 USP UNITS PROTEASE
Related Searches:
NDC00517-2110-25
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012931905
NSN
6505-01-293-1905
NDC00517-2110-25
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012931905
NSN
6505-01-293-1905
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
HYPAQUE-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012931906
NSN
6505-01-293-1906
HYPAQUE-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012931906
NSN
6505-01-293-1906
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-0779-02
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012931906
NSN
6505-01-293-1906
NDC00024-0779-02
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505012931906
NSN
6505-01-293-1906
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
CLEOCIN ADDVANTAGE
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505012933319
NSN
6505-01-293-3319
CLEOCIN ADDVANTAGE
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505012933319
NSN
6505-01-293-3319
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLINDAMYCIN INJECTION USP STERILE 150MG/ML 4ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 600 MG IN A SINGLE-DOSE,15 ML CAPACITY GLASS VIAL W/DOUBLED LEAD SCREW TO INTERLOCK W/INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
CLEOCIN PHOSPHAT
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505012933319
NSN
6505-01-293-3319
CLEOCIN PHOSPHAT
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505012933319
NSN
6505-01-293-3319
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLINDAMYCIN INJECTION USP STERILE 150MG/ML 4ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 600 MG IN A SINGLE-DOSE,15 ML CAPACITY GLASS VIAL W/DOUBLED LEAD SCREW TO INTERLOCK W/INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
NDC00009-3124-03
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505012933319
NSN
6505-01-293-3319
NDC00009-3124-03
CLINDAMYCIN INJECTION,USP
NSN, MFG P/N
6505012933319
NSN
6505-01-293-3319
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLINDAMYCIN INJECTION USP STERILE 150MG/ML 4ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 600 MG IN A SINGLE-DOSE,15 ML CAPACITY GLASS VIAL W/DOUBLED LEAD SCREW TO INTERLOCK W/INLET PORT OF DEXTROSE INJECTION,6505-01-260-1237,6505-01-260-1238,6505-01-260-1239 AND SODIUM CHLORIDE INJECTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715;
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD
Related Searches:
NDC51284-0468-02
TANNIC ACID GEL
NSN, MFG P/N
6505012935580
NSN
6505-01-293-5580
MFG
ZILA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V TANNIC ACID ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TANNIC ACID GEL 7% 0.25OZ TUBE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZILA PHARMACEUTICALS INC
PRIMARY CONTAINER CONTENT QUANTITY: 0.250 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: USE PREFERRED UPC: 3-50486-46802-4 IN ACCORDANCE WITH THE JDF
